Literature DB >> 28975481

Interaction of allogeneic adipose tissue-derived stromal cells and unstimulated immune cells in vitro: the impact of cell-to-cell contact and hypoxia in the local milieu.

Aleksandra N Gornostaeva1, Elena R Andreeva2, Polina I Bobyleva1, Ludmila B Buravkova1.   

Abstract

Multipotent mesenchymal stem cells (MSCs) are an attractive tool for cell therapy and regenerative medicine. Being applied in vivo, allogeneic MSCs are faced with both activated and unstimulated immune cells. The effects of MSCs on activated immune cells are well described and are mainly suppressive. Less is known about the interaction of MSCs with unstimulated immune cells. We evaluated the contribution of tissue-related O2 level ("physiological" hypoxia-5% O2) and cell-to-cell contact to the interaction between allogeneic adipose tissue-derived MSCs (ASCs) and unstimulated peripheral blood mononuclear cells (PBMCs). Under both O2 levels, ASCs affected the immune response by elevating the proportion of CD69+ T cells and modifying the functional activity of unstimulated PBMCs, providing a significant reduction of ROS level and activation of lysosome compartment. "Physiological" hypoxia partially attenuated the ASC modulation of PBMC function, reducing CD69+ cell activation and more significantly supressing ROS. In direct co-culture, the ASC effects were more pronounced. PBMC viability was preferentially maintained, and the lymphocyte subset ratio was altered in favour of B cells. Our findings demonstrate that allogeneic ASCs do not enhance the activation of unstimulated immune cells and can provide supportive functions. The "hypoxic" phenotype of ASCs may be more "desirable" for the interaction with allogeneic immune cells that may be required in cell therapy protocols.

Entities:  

Keywords:  Cell-to-cell interaction; Hypoxia; Immune response; Immunosuppression; Lymphocytes; MSC

Year:  2017        PMID: 28975481      PMCID: PMC5809659          DOI: 10.1007/s10616-017-0144-x

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  48 in total

Review 1.  Mesenchymal stem cells: cell biology and potential use in therapy.

Authors:  Moustapha Kassem; Malthe Kristiansen; Basem M Abdallah
Journal:  Basic Clin Pharmacol Toxicol       Date:  2004-11       Impact factor: 4.080

2.  Human mesenchymal stem cells promote survival of T cells in a quiescent state.

Authors:  Federica Benvenuto; Stefania Ferrari; Ezio Gerdoni; Francesca Gualandi; Francesco Frassoni; Vito Pistoia; Gianluigi Mancardi; Antonio Uccelli
Journal:  Stem Cells       Date:  2007-03-29       Impact factor: 6.277

3.  [Characteristics of human lipoaspirate-isolated mesenchymal stromal cells cultivated under a lower oxygen tension].

Authors:  L B Buravkova; O S Grinakovskaia; E P Andreeva; A P Zhambalova; M P Kozionova
Journal:  Tsitologiia       Date:  2009

Review 4.  The MSC curtain that stops the immune system.

Authors:  Arnold I Caplan; J Michael Sorrell
Journal:  Immunol Lett       Date:  2015-06-14       Impact factor: 3.685

Review 5.  Mesenchymal stem cells: immune evasive, not immune privileged.

Authors:  James A Ankrum; Joon Faii Ong; Jeffrey M Karp
Journal:  Nat Biotechnol       Date:  2014-02-23       Impact factor: 54.908

6.  Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: the role of adenosine receptor A(2).

Authors:  Jintang Sun; Yan Zhang; Meixiang Yang; Yun Zhang; Qi Xie; Zewu Li; Zhaogang Dong; Yongmei Yang; Biping Deng; Alei Feng; Weixu Hu; Haiting Mao; Xun Qu
Journal:  Cell Mol Immunol       Date:  2009-12-23       Impact factor: 11.530

7.  Low ATP level is sufficient to maintain the uncommitted state of multipotent mesenchymal stem cells.

Authors:  L B Buravkova; Y V Rylova; E R Andreeva; A V Kulikov; M V Pogodina; B Zhivotovsky; V Gogvadze
Journal:  Biochim Biophys Acta       Date:  2013-06-04

Review 8.  PUMA, a potent killer with or without p53.

Authors:  J Yu; L Zhang
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

9.  Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells.

Authors:  Warren L Grayson; Feng Zhao; Bruce Bunnell; Teng Ma
Journal:  Biochem Biophys Res Commun       Date:  2007-05-22       Impact factor: 3.575

10.  Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT).

Authors:  Philippe Bourin; Bruce A Bunnell; Louis Casteilla; Massimo Dominici; Adam J Katz; Keith L March; Heinz Redl; J Peter Rubin; Kotaro Yoshimura; Jeffrey M Gimble
Journal:  Cytotherapy       Date:  2013-04-06       Impact factor: 5.414

View more
  3 in total

Review 1.  Current understanding of the immunosuppressive properties of mesenchymal stromal cells.

Authors:  Ligia Lins de Castro; Miquéias Lopes-Pacheco; Daniel Jay Weiss; Fernanda Ferreira Cruz; Patricia Rieken Macêdo Rocco
Journal:  J Mol Med (Berl)       Date:  2019-03-22       Impact factor: 4.599

2.  Differentiation and Functionality of Bone Marrow-Derived Mast Cells Depend on Varying Physiologic Oxygen Conditions.

Authors:  Helene Möllerherm; Karsten Meier; Kathrin Schmies; Herbert Fuhrmann; Hassan Y Naim; Maren von Köckritz-Blickwede; Katja Branitzki-Heinemann
Journal:  Front Immunol       Date:  2017-11-30       Impact factor: 7.561

3.  Cytogenetic and Transcriptomic Analysis of Human Endometrial MSC Retaining Proliferative Activity after Sublethal Heat Shock.

Authors:  Mariia A Shilina; Tatiana M Grinchuk; Olga V Anatskaya; Alexander E Vinogradov; Larisa L Alekseenko; Artem U Elmuratov; Nikolai N Nikolsky
Journal:  Cells       Date:  2018-10-25       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.